Stock market
Earnings call transcript: Concord Biotech Q2 2026 profit miss hits shares
Read the full story at Investing.comOpen in the live monitor
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More on Stock market
- GSK shares dive as weaker sales and mounting costs unnerve investorsBritish pharma company reports declining profits amid concerns over looming patent loss of its blockbuster HIV drugShares in GSK slid on Wednesday despite the UK drugmaker reporting better-than-exp...
- Earnings call transcript: Canada Packers Q3 2026 profit miss weighs on shares
- Nigeria's Dangote oil refinery closes 'historic' IPOAfrica's largest ever initial public offering closed on Wednesday after raising funds from investors in 120 countries. The IPO for Nigeria's Dangote Petroleum Refinery was extended by two weeks to...
- NXP Semiconductors' outlook disappoints Wall Street
- LG CNS and D-Wave Announce Strategic Relationship to Advance Quantum Optimization Adoption in South KoreaSEOUL, South Korea & PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing an...
- Extreme Networks Reports First Quarter Fiscal Year 2027 Financial ResultsMORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (“Extreme”) (Nasdaq: EXTR) today released financial results for its first quarter ended September 30, 2026. “Extreme delivered its seventh...